Pituitary Gland News and Research

RSS
New genome-wide association study sheds light on the underlying biology of polycystic ovary syndrome

New genome-wide association study sheds light on the underlying biology of polycystic ovary syndrome

FDA accepts Chiasma's NDA filing for octreotide capsules for treatment of adult patients with acromegaly

FDA accepts Chiasma's NDA filing for octreotide capsules for treatment of adult patients with acromegaly

Endocrine Society recommends removal of tumor as first-line treatment for endogenous Cushing's syndrome

Endocrine Society recommends removal of tumor as first-line treatment for endogenous Cushing's syndrome

Vanderbilt researchers hope to give new dexterity to needlescopic surgery with tiny mechanical wrist

Vanderbilt researchers hope to give new dexterity to needlescopic surgery with tiny mechanical wrist

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris plans to conduct Macrilen Phase 3 clinical study for AGHD

Aeterna Zentaris plans to conduct Macrilen Phase 3 clinical study for AGHD

Letrozole helps restore fertility in obese, infertile men

Letrozole helps restore fertility in obese, infertile men

Chiasma closes $70 million Series E financing round

Chiasma closes $70 million Series E financing round

Harmless plant extract can help treat Cushing Disease

Harmless plant extract can help treat Cushing Disease

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

FDA grants orphan drug status to NBI-77860 for treatment of congenital adrenal hyperplasia

FDA grants orphan drug status to NBI-77860 for treatment of congenital adrenal hyperplasia

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

SAFit-ligands provide foundation for novel treatment of stress-related psychiatric disorders

SAFit-ligands provide foundation for novel treatment of stress-related psychiatric disorders

PET/CT may improve differentiation of PTSD from MTBI

PET/CT may improve differentiation of PTSD from MTBI

Researchers discover molecular switch that triggers stress processes in the brain

Researchers discover molecular switch that triggers stress processes in the brain

New Clinical Practice Guideline for diagnosis, treatment of acromegaly

New Clinical Practice Guideline for diagnosis, treatment of acromegaly

Rare neuroendocrine tumours may be misdiagnosed as Cushing’s disease

Rare neuroendocrine tumours may be misdiagnosed as Cushing’s disease

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics